Longitudin
Internal Medicine
2021-05-06

Longitudinal study tracks humoral immunity response against SARS-CoV-2 in convalescent individuals

When researchers conducted a longitudinal assessment of humoral immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 32 convalescent individuals up to 8 months post-symptom onset, they observed that immunoglobulin (Ig)M levels and the neutralising capacity of plasma in these individuals decreases rapidly, whereas IgG level and Fc-effector activity were more sustained. Meanwhile, SARS-CoV-2-specific B cell immunity persisted despite overall antibody decline. These findings were published in Cell Reports Medicine. “Our findings aid in the understanding o...

Close Moni
Internal Medicine
2021-05-04

Close Monitoring for Heart Risk Needed if Breast, Prostate Cancer Treatment Includes Hormones

The hormonal therapies used to treat many breast and prostate cancers increase the risk of a myocard...

American H
Internal Medicine
2021-05-03

American Heart Association/American Stroke Association Stroke Council Leadership provides guida...

The American Heart Association/American Stroke Association Stroke Council Leadership has provided gu...

Videos from category: Cardiology

The evolut
8:05

The evolution of hypertension management: The increasing role of triple therapy in clinical practice

ESH-ISH 2021
Long term
17:22

Long term benefits of blood pressure treatment on the incidence of atrial fibrillation, heart failure and cardiovascular morbidity and mortality: 20-years follow-up of ASCOT-legacy

ESH-ISH 2021
ESH-ISH 20
11:38

ESH-ISH 2021 Late-Breakers Session

ESH-ISH 2021
No(t) a cl
11:51

No(t) a class effect - A crowded class

ESH-ISH 2021

Videos from category: Dermatology

Psoriasis
6:51

Psoriasis is a systemic disease

EADV 2020
New non-al
6:36

New non-allergenic, anti-inflammatory fragrance could be game changer for dry skin sufferers

EADV 2020
New eviden
7:47

New evidence shows that systemic inflammation in psoriasis can be treated orally with a non-living strain of a commensal microbe

EADV 2020
New Resear
4:08

New Research Reveals that Risky Sexual Behaviour and STIs are on the Rise Despite COVID-19 Pandemic

EADV 2020

Videos from category: Diabetology

Accumulate
8:58

Accumulated CV data from SGLT2i outcomes trials

EASD 2020
Summary of
7:44

Summary of clinical and scientific topics discussed at EASD 2020 congress

EASD 2020
Remission
10:22

Remission of type 2 diabetes with return of insulin secretory function restores normal pancreas morphology

EASD 2020
Effects of
11:28

Effects of empagliflozin on physical activity and compensatory appetite responses in people with type 2 diabetes: the SEESAW trial

EASD 2020

Videos from category: Gastroenterology

Duodenal m
11:01

Duodenal mucosal resurfacing shown to discontinue insulin treatment in majority of type 2 diabetes patients and aid weight loss

UEG 2020
Allergy-re
7:48

Allergy-related diseases and IBS

UEG 2020
Transmural
4:50

Transmural healing in IBD

ECCO 2020
How to seq
2:20

How to sequence advanced therapies in IBD

ECCO 2020

Videos from category: Hematology

Optimal Du
3:55

Optimal Duration of Imatinib Treatment / Deep Molecular Response for Treatment-Free Remission after Imatinib Discontinuation from a Canadian Tyrosine Kinase Inhibitor Discontinuation Trial

ASH 2020
Effect of
4:54

Effect of Pembrolizumab Monotherapy Versus Brentuximab Vedotin on Patients with Relapsed/Refractory Classical Hodgkin Lymphoma: Exploratory Analysis of the Randomized, Phase 3 Keynote-204 Study By Prior Lines of Therapy

ASH 2020
Comparison
7:32

Comparison of Gilteritinib and Salvage Chemotherapy in FLT3-Mutated Acute Myeloid Leukemia on the Number Needed to Treat for Various Clinical Outcomes: A Secondary Analysis of the Admiral Trial

ASH 2020
Comprehens
14:08

Comprehensive summary of novel multiple myeloma data from ASH2020

ASH 2020

Videos from category: Internal Medicine

Which are
4:59

Which are the most promising new medications in phase 3 clinical trials for the treatment of painful large joint arthritis?

PAINWeek 2020
What is th
14:04

What is the role of transdermal fentanyl patches in management of cancer pain?

PAINWeek 2020
Optimising
8:42

Optimising the monitoring and treatment of SSc-ILD

EULAR 2020
Leading ro
7:42

Leading role of hypertension in CV risk scene

ESH 2019

Videos from category: Oncology

Detailed s
16:51

Detailed summary of the Consensus Session of the SG-BCC 2021

St. Gallen BCC 2021
How can ge
5:53

How can genomic tests help in clinical decision making for adjuvant treatment of ER+ breast cancer?

St. Gallen BCC 2021
Care for p
7:47

Care for patients with HER2-positive breast cancer

St. Gallen BCC 2021
Highlights
4:21

Highlights of the 17th St. Gallen International Breast Cancer Conference

St. Gallen BCC 2021

Videos from category: Psychiatry

Novel Phar
8:13

Novel Pharmacotherapeutic Strategies for Regaining Control over Alcohol Intake in Alcohol Use Disorder

EPA 2021
Obstetric
6:010

Obstetric Complications: The Forgotten Risk Factor for Schizophrenia

EPA 2021
Consequenc
7:54

Consequences of COVID-19 Outbreak on Mental Health

EPA 2021
Meeting th
15:41

Meeting the challenges of schizophrenia care during the COVID-19 pandemic

EPA 2021

Videos from category: Respiratory

Resetting
7:38

Resetting the agenda: a new approach to asthma in GINA 2019

ERS 2019
Personalis
5:14

Personalised medicine applied to inhaler selection

ERS 2019
Severe ast
8:04

Severe asthma guidelines: Update 2019

ERS 2019
Hot topics
3:58

Hot topics in respiratory medicine and science

ERS 2019

Suggested videos

By Author
By Topic
By Congress
7:07
KEYNOTE-024 5-year OS update: first-line (1L) pembrolizumab (pembro) vs platinum-based chemotherapy (chemo) in patients (pts) with metastatic NSCLC and PD-L1 tumor proportion score (TPS) ≥50%
ESMO 2020
13:09
A Polypill for Primary Prevention of Cardiovascular Disease in Intermediate Risk People: Results of the International Polycap Study (TIPS)-3
AHA 2020
4:21
Highlights of the 17th St. Gallen International Breast Cancer Conference
St. Gallen BCC 2021
11:15
EXPLORER-HCM: Efficacy and Safety of Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
ESC 2020
6:13
Breast cancer highlights from ESMO2020
ESMO 2020
11:06
IMpassion031: Results from a phase III study of neoadjuvant atezolizumab + chemotherapy in early triple-negative breast cancer
ESMO 2020
15:58
2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease
ESC 2020
8:49
First safety and efficacy results of PRADO: A phase II study of personalized response-driven surgery and adjuvant therapy after neoadjuvant ipilimumab (IPI) and nivolumab (NIVO) in resectable stage III melanoma
ASCO 2020
9:01
A Three-arm N-of-1 Trial With Statin, Placebo and Tablet Free Periods, to Verify Side Effects and Identify Their Cause: The SAMSON Trial
AHA 2020
7:44
Summary of clinical and scientific topics discussed at EASD 2020 congress
EASD 2020
6:22
Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study
ASH 2019
8:34
State of the Science: The Six Pillars of Heart Failure Therapy
AHA 2020
20:34
Triple negative breast cancer highlights in ESMO 2020
ESMO 2020
9:22
MONARCH-E trial: Abemaciclib reduces recurrence in HR+ high risk early breast cancer
ESMO 2020
14:31
ESC Gold Medal 2020 Winner: Kari Stefansson
ESC 2020
11:28
Effects of empagliflozin on physical activity and compensatory appetite responses in people with type 2 diabetes: the SEESAW trial
EASD 2020
9:42
De-escalation of early breast cancer therapy: Umberto Veronesi’s legacy
St. Gallen BCC 2021
8:42
Safety and efficacy of the oral JAK3/TEC inhibitor PF-06651600 and the oral TYK2/JAK1 inhibitor PF-06700841 in a withdrawal/retreatment extension study in patients with alopecia areata
EADV 2019
9:11
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study
EHA 2020
13:30
First-line nivolumab + ipilimumab combined with 2 cycles of platinum-based chemotherapy vs 4 cycles of chemo in advanced non-small cell lung cancer: Patient-reported outcomes from CheckMate 9LA
ESMO 2020
3:25
Single cell RNA seq of immune infiltrates
EADO 2019
7:02
Clinical Impact of Ibrutinib with R-CHOP in Untreated Non-GCB DLBCL Co-Expressing BCL2 and MYC Genes in the Phase 3 Phoenix Trial
ASH 2019
17:43
Recognizing and Addressing Risk in Patients with HR-positive, HER2-negative Early Breast Cancer
St. Gallen BCC 2021
7:33
2020 ESC Guidelines on Adult Congenital Heart Disease
ESC 2020
7:11
KEYNOTE-204: Randomized, open-label, phase III study of pembrolizumab (pembro) versus brentuximab vedotin (BV) in relapsed or refractory classic Hodgkin lymphoma (R/R cHL)
ASCO 2020
7:48
Allergy-related diseases and IBS
UEG 2020
9:57
Coronary Artery Disease: What was new at ESC Congress 2020?
2020 Scientific Congress of the Hungarian Society of Cardiology
8:36
Why We Should Still Care about Glycemic Lowering Strategies for Type 2 Diabetes
EASD 2019
6:46
The Efficacy and Safety of Evinacumab in Patients With Refractory Hypercholesterolemia
AHA 2020
Search by Scientific Content
Search by Congress
Search:
Date
Filters:
The evolut
8:05
Title Description

The evolution of hypertension management: The increasing role of triple therapy in clinical practice

Presenter: Giuseppe Mancia
Cardiology : Hypertension
ESH-ISH 2021
Long term
17:22
Title Description

Long term benefits of blood pressure treatment on the incidence of atrial fibrillation, heart failure and cardiovascular morbidity and mortality: 20-years follow-up of ASCOT-legacy

Presenter: Peter Sever
Cardiology : Hypertension
ESH-ISH 2021
Novel Phar
8:13
Title Description

Novel Pharmacotherapeutic Strategies for Regaining Control over Alcohol Intake in Alcohol Use Disorder

Presenter: Benjamin Rolland
Psychiatry
EPA 2021
ESH-ISH 20
11:38
Title Description

ESH-ISH 2021 Late-Breakers Session

Presenter: Anna F. Dominiczak
Cardiology : Hypertension
ESH-ISH 2021
Meeting th
15:41
Title Description

Meeting the challenges of schizophrenia care during the COVID-19 pandemic

Presenter: Silvana Galderisi
Psychiatry
EPA 2021
Consequenc
7:54
Title Description

Consequences of COVID-19 Outbreak on Mental Health

Presenter: Celso Arango
Psychiatry
EPA 2021
Obstetric
6:010
Title Description

Obstetric Complications: The Forgotten Risk Factor for Schizophrenia

Presenter: Robin Murray
Psychiatry
EPA 2021
Detailed s
16:51
Title Description

Detailed summary of the Consensus Session of the SG-BCC 2021

Presenter: Walter Weber
Oncology : Breast Cancer
St. Gallen BCC 2021
Do we need
6:17
Title Description

Do we need beta blockers in hypertension?

Presenter: Sverre Erik Kjeldsen
Cardiology : Hypertension
ESH-ISH 2021
Difficult
7:19
Title Description

Difficult to Treat Depression

Presenter: Andrea Fiorillo
Psychiatry
EPA 2021
Consequenc
7:36
Title Description

Consequences of COVID-19 Outbreak on Mental Health

Presenter: Axel Börsch-Supan
Psychiatry
EPA 2021
Impact of
11:02
Title Description

Impact of hypertension in the morbidity and mortality in diabetes mellitus: A real-world data

Presenter: Josep Redon
Cardiology : Hypertension
ESH-ISH 2021
Improving
12:21
Title Description

Improving the management of hypertension: acting on key factors

Presenter: Neil Poulter
Cardiology : Hypertension
ESH-ISH 2021
No(t) a cl
11:51
Title Description

No(t) a class effect - A crowded class

Presenter: Athanasios John Manolis
Cardiology : Hypertension
ESH-ISH 2021
Highlights
7:39
Title Description

Highlights of the EPA 2021

Presenter: Peter Falkai
Psychiatry
EPA 2021
The ISH 20
6:13
Title Description

The ISH 2020 global hypertension practice guidelines

Presenter: Alta Schutte
Cardiology : Hypertension
ESH-ISH 2021

Lectures

Carfilzomi
6:49

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis Results from the Randomized, Open-Label, Phase 3 Study Candor

Presenter: Saad Z. Usmani
Hematology
Inhibition
6:22

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Presenter: Alexander Röth
Hematology
The QUAZAR
8:20

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

Presenter: Andrew H. Wei
Hematology
Validation
7:11

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Presenter: David A. Williams
Hematology
A Randomiz
4:40

A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk First Relapse of B-ALL in Children and Adolescents/Young Adults Demonstrates Superior Efficacy and Tolerability of Blinatumomab

Presenter: Patrick A. Brown
Hematology
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
Cardiology
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
Cardiology
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
Cardiology
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
Cardiology
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
Cardiology
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients.

Presenter: Andreas Goette
Cardiology
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Cardiology
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
Cardiology
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
Cardiology
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Cardiology
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
Cardiology